Is mPGES-1 a promising target for pain therapy?
- 31 August 2006
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 27 (8) , 399-401
- https://doi.org/10.1016/j.tips.2006.06.001
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2006
- Redirection of Eicosanoid Metabolism in mPGES-1-deficient MacrophagesJournal of Biological Chemistry, 2005
- Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1Journal of Biological Chemistry, 2004
- Membrane-associated prostaglandin E synthase-1 is required for neuropathic painNeuroReport, 2004
- Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic painNeuroscience, 2004
- Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresisNature Neuroscience, 2003
- Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthaseProceedings of the National Academy of Sciences, 2003
- Prostaglandin E synthaseProstaglandins & Other Lipid Mediators, 2002
- Prostaglandins and cycloxygenases in the spinal cordProgress in Neurobiology, 2001
- Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2Journal of Biological Chemistry, 2000